高级检索
    廖宁. 卧薪尝胆,韬光养晦——乳腺癌抗血管生成靶向治疗之路[J]. 循证医学, 2012, 12(3): 134-137. DOI: 10.3969/j.issn.1671-5144.2012.03.011
    引用本文: 廖宁. 卧薪尝胆,韬光养晦——乳腺癌抗血管生成靶向治疗之路[J]. 循证医学, 2012, 12(3): 134-137. DOI: 10.3969/j.issn.1671-5144.2012.03.011
    shu
    LIAO Ning. To Undergo Self-Imposed Hardships, and Hide One’s Capacities and Bide One’s Time: Breast Cancer Antiangiogenesis Targeted Therapy[J]. Journal of Evidence-Based Medicine, 2012, 12(3): 134-137. DOI: 10.3969/j.issn.1671-5144.2012.03.011
    Citation: LIAO Ning. To Undergo Self-Imposed Hardships, and Hide One’s Capacities and Bide One’s Time: Breast Cancer Antiangiogenesis Targeted Therapy[J]. Journal of Evidence-Based Medicine, 2012, 12(3): 134-137. DOI: 10.3969/j.issn.1671-5144.2012.03.011
    shu

    卧薪尝胆,韬光养晦——乳腺癌抗血管生成靶向治疗之路

    To Undergo Self-Imposed Hardships, and Hide One’s Capacities and Bide One’s Time: Breast Cancer Antiangiogenesis Targeted Therapy

      摘要
    • 摘要: 乳腺癌是女性最常见恶性肿瘤之一, 其中约1/3的早期乳腺癌患者最终会发生疾病进展而成为晚期乳腺癌。伴随着个体化治疗时代的来临, 在晚期乳腺癌治疗中, 抗血管生成靶向治疗成为重要的组成部分。

       

      • HTML全文
      • 参考文献(17)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回